Insulin Denied by Insurance? Coverage Rights for Insulin and Diabetes Medications

If your insurance company denied coverage for an insulin pump or continuous glucose monitor (CGM), you are not alone — these devices are among the most frequently denied diabetes treatments in the United States, despite overwhelming clinical evidence that they improve glycemic control, reduce dangerous hypoglycemia, and lower the risk of long-term complications including kidney failure, neuropathy, and cardiovascular disease. The American Diabetes Association Standards of Medical Care in Diabetes and expanded 2023 CMS coverage determinations both strongly support these devices for eligible patients. A denial is not final: with the right documentation and a targeted appeal strategy, many patients successfully reverse these decisions.

Why Insurers Deny Insulin Pumps and CGMs

"Not medically necessary" for this patient's profile. Insurers argue that multiple daily injections (MDI) or fingerstick blood glucose testing are adequate alternatives. This position directly contradicts the ADA Standards of Medical Care, which support CGM use for all adults with Type 1 diabetes and for insulin-using adults with Type 2 diabetes. Plans often apply HbA1c thresholds — requiring the patient's level to be above 8.0% — that ignore clinical indications including hypoglycemia unawareness and glycemic variability.

Type 2 diabetes exclusions. Many plans categorically restrict insulin pump and CGM coverage to Type 1 diabetes patients (ICD-10: E10.x). This is inconsistent with clinical evidence showing benefit for many insulin-using Type 2 patients (E11.x) and with the 2023 CMS National Coverage Determination, which expanded CGM coverage to all Medicare beneficiaries with diabetes who use insulin, regardless of diabetes type.

Step therapy and MDI documentation gaps. Plans require documented failure of an optimized MDI regimen before approving pump therapy. When medical records do not clearly show the MDI regimen trialed, the duration of that trial, and the glycemic outcomes — including HbA1c and hypoglycemic episode frequency — the plan denies for step therapy non-compliance rather than clinical grounds.

Device-specific formulary restrictions. Plans cover specific CGM brands (Dexcom G7, Abbott Libre 3) or specific pump models and deny newer automated insulin delivery (AID) systems or tubeless pumps such as the Omnipod system as "not on formulary" or "investigational," even when the requested device is the most clinically appropriate option.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization documentation errors. Missing documentation, incorrect HCPCS codes (E0784 for insulin pumps; A9276 for CGM therapeutic sensors), or incomplete physician attestation in the prior authorization request generates administrative denials that are entirely unrelated to clinical merit and are among the easiest to reverse.

How to Appeal an Insulin Pump or CGM Denial

Step 1: Obtain the Denial and the Insurer's Coverage Policy

Request your denial letter, EOB)" class="auto-link">Explanation of Benefits, and the insurer's clinical coverage policy for insulin pumps or CGMs. This policy specifies exactly what the plan requires — HbA1c thresholds, hypoglycemia frequency standards, MDI documentation requirements — and enables you to identify precisely which criterion your documentation did not satisfy. For Medicare Advantage denials, request the applicable Local Coverage Determination from your MAC jurisdiction.

Step 2: Build Your Endocrinologist's Letter of Medical Necessity

Your endocrinologist's letter is the foundation of the appeal. It must include the ICD-10 diagnosis code (E10.649 for Type 1 diabetes with hypoglycemia; E11.649 for Type 2 diabetes with hypoglycemia), current HbA1c and a trend of historical values, documentation of hypoglycemic episodes with dates and severity, a statement on hypoglycemia unawareness if present, evidence that MDI was trialed and was insufficient, and a specific citation to the ADA Standards of Medical Care in Diabetes supporting the device for this patient's clinical profile. Hypoglycemia unawareness is a particularly strong standalone indication and should be explicitly documented.

Step 3: Document Hypoglycemia and Glycemic Variability Quantitatively

Gather blood glucose meter download reports or CGM trial data covering at least two to three weeks showing glycemic variability (coefficient of variation), time-below-range, and the frequency of hypoglycemic events. Document severe episodes specifically: emergency room visits, 911 calls, glucagon prescription and use, or episodes requiring assistance from another person. These objective data points are difficult for the insurer's reviewing clinician to disregard, particularly when the ADA Standards explicitly support device use for patients with demonstrated hypoglycemia risk.

Step 4: Document MDI Failure and Request Peer-to-Peer Review

For pump appeals: compile prescription records and clinical notes showing the specific MDI regimen — basal and bolus insulin analogs, doses, titration history — and the glycemic outcomes achieved. Then ask your endocrinologist to request a peer-to-peer review with the insurer's medical director within five days of the denial. A clinical conversation reviewing HbA1c trend, hypoglycemia frequency, and failed MDI regimen resolves many device denials at this stage without a full written appeal.

Step 5: File the Internal Appeal Citing ADA Standards and CMS Coverage

Submit your written internal appeal addressing every denial criterion specifically. Cite the ADA Standards of Medical Care in Diabetes (current year) for the specific recommendation supporting the device — for example, the ADA's recommendation for CGM use in all adults with Type 1 diabetes and insulin-using adults with Type 2. For Medicare and Medicare Advantage denials, cite the 2023 CMS National Coverage Determination for CGMs (NCD 40.2) and — for pumps — HCPCS E0784 and the applicable Local Coverage Determination. For state-regulated plans in California, Illinois, or New York, cite the applicable diabetes device mandate. Under ACA §2719 (42 U.S.C. §300gg-19), the plan must provide a written decision within 60 days.

Step 6: Escalate to External Independent Review: Complete Guide" class="auto-link">External Review and State Regulators

If the internal appeal is denied, file for independent external review with an endocrinology-experienced reviewer. For Medicaid denials, request a state fair hearing. An independent endocrinologist evaluating your case against ADA guidelines — rather than the insurer's internal criteria — provides the most powerful check on an erroneous denial. For state-regulated plans in states with diabetes device mandates, file a complaint with your state insurance commissioner simultaneously. For ERISA employer plans, file with the Department of Labor EBSA at 1-866-444-3272.

What to Include in Your Appeal

• Endocrinologist's letter with ICD-10 code, current and historical HbA1c data, hypoglycemia documentation, MDI history, and ADA Standards of Medical Care citation for the specific device recommendation applicable to this patient
• Blood glucose meter or CGM download data showing glycemic variability, time-below-range, and hypoglycemic event frequency over at least two to three weeks
• Documentation of severe hypoglycemic episodes — ER records, glucagon use, physician documentation of episodes requiring third-party assistance — establishing the risk profile that supports device approval
• MDI prescription and pharmacy records (for pump appeals) showing the specific regimen trialed, duration, and glycemic outcomes showing that MDI did not achieve the required clinical goals

Fight Back With ClaimBack

Insulin pump and CGM denials are among the most winnable insurance appeals when the clinical record is complete. ADA guidelines, expanded CMS coverage, and state mandates in multiple states all support these devices. ClaimBack generates a professional, diabetes-specific appeal letter in 3 minutes, referencing the specific ADA and CMS criteria applicable to your diagnosis code and device type.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal